Ketanserin: Difference between revisions

Jump to navigation Jump to search
m (Protected "Ketanserin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 28: Line 28:
{{CMG}}
{{CMG}}


{{Editor Join}}
 


==Overview==
==Overview==
Line 48: Line 48:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
{{SIB}}
 
[[ja:ケタンセリン]]
[[ja:ケタンセリン]]

Revision as of 16:42, 9 August 2012

Ketanserin
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22FN3O3
Molar mass395.43 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Ketanserin is a serotonin receptor antagonist. It has the highest affinity for the serotonin 5-HT2A receptor, but also binds less potently to the 5-HT2C, 5-HT2B, 5-HT1D, alpha-adrenergic, and dopamine receptors. With tritium radioactively labeled ketanserin is used as a radioligand for the serotonin 5-HT2A receptor, e.g. in receptor binding assays.

Ketanserin was discovered at Janssen Pharmaceutica in 1980.

It is classified as an antihypertensive by the World Health Organization[1] and the National Institute of Health.[2]

References


Template:WikiDoc Sources